Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00401596
Status:
COMPLETED
Last Update Posted:
2014-03-19
First Post:
2006-11-17
Brief Title:
A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients ALTO
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
A Multicenter Randomized Controlled Open-Label Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Subjects Already Treated With Other Therapies ALTO
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This was a multicenter open label randomized controlled safety trial in subjects aged 6-75 years with a diagnosis of moderate to severe persistent asthma A total of 1899 subjects were randomized 21 to either the active treatment group or the control group Upon successful completion of the screening period 2 weeks each subject entered the 24 week study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None